Snail, Slug, and Smad-interacting protein 1 as novel parameters of disease aggressiveness in metastatic ovarian and breast carcinoma
- PMID: 15742334
- DOI: 10.1002/cncr.20946
Snail, Slug, and Smad-interacting protein 1 as novel parameters of disease aggressiveness in metastatic ovarian and breast carcinoma
Abstract
Background: It was demonstrated previously that the Snail family of transcription factors and Smad-interacting protein 1 (Sip1) regulate E-cadherin and matrix metalloproteinase 2 (MMP-2) expression, cellular morphology, and invasion in carcinoma. For the current study, the authors analyzed the relation between the expression of Snail, Slug, and Sip1; the expression of MMP-2 and E-cadherin; and clinical parameters in patients with metastatic ovarian and breast carcinoma.
Methods: One hundred one fresh-frozen, malignant effusions from patients who were diagnosed with gynecologic carcinomas (78 ovarian carcinomas and 23 breast carcinomas) were studied for mRNA expression of Snail, Slug, Sip1, MMP-2, and E-cadherin using reverse transcriptase-polymerase chain reaction analysis. Snail mRNA and E-cadherin protein expression levels also were studied in ovarian carcinoma effusions using in situ hybridization and immunocytochemistry. The results were analyzed for possible correlation with clinicopathologic parameters in both tumor types.
Results: E-cadherin mRNA expression was lower in breast carcinoma (P = 0.001), whereas Snail expression was higher (P = 0.003). The Snail/E-cadherin ratio (P < 0.001) and the Sip1/E-cadherin ratio (P = 0.002) were higher in breast carcinomas. Sip1 mRNA expression (P < 0.001) and Slug mRNA expression (P < 0.001) were correlated with the expression of MMP-2 in ovarian carcinomas. The Sip1/E-cadherin ratio was higher in primary ovarian carcinomas at the time of diagnosis compared with postchemotherapy ovarian carcinoma effusions (P = 0.003), higher in Stage IV tumors compared with Stage III tumors (P = 0.049), and higher in pleural effusions compared with peritoneal effusions (P = 0.044). In a univariate survival analysis of patients with ovarian carcinoma, a high Sip1/E-cadherin ratio predicted poor overall survival (P = 0.018). High E-cadherin mRNA expression predicted better disease-free survival (P = 0.023), with a similar trend for a low Slug/E-cadherin ratio (P = 0.07). High Snail mRNA expression predicted shorter effusion-free survival (P = 0.008), disease-free survival (P = 0.03), and overall survival (P = 0.008) in patients with breast carcinoma.
Conclusions: Transcription factors that regulate E-cadherin were expressed differentially in metastatic ovarian and breast carcinoma. Snail may predict a poor outcome in patients who have breast carcinoma metastatic to effusions. E-cadherin expression generally was conserved in effusions from patients with ovarian carcinoma, but the subset of patients with postulated Sip1-induced repression of this adhesion molecule had a significantly worse outcome. This finding was in agreement with the stronger suppression of E-cadherin by Snail and Sip1 in breast carcinoma effusions, a clinical condition associated with extremely poor survival.
(c) 2005 American Cancer Society.
Similar articles
-
Expression of Snail, Slug and Sip1 in malignant mesothelioma effusions is associated with matrix metalloproteinase, but not with cadherin expression.Lung Cancer. 2006 Dec;54(3):309-17. doi: 10.1016/j.lungcan.2006.08.010. Epub 2006 Sep 25. Lung Cancer. 2006. PMID: 16996643
-
The clinical role of phospholipase A2 isoforms in advanced-stage ovarian carcinoma.Gynecol Oncol. 2006 Dec;103(3):831-40. doi: 10.1016/j.ygyno.2006.06.042. Epub 2006 Aug 17. Gynecol Oncol. 2006. PMID: 16919315
-
Expression of E-cadherin transcriptional regulators in ovarian carcinoma.Virchows Arch. 2006 Nov;449(5):520-8. doi: 10.1007/s00428-006-0274-6. Epub 2006 Oct 6. Virchows Arch. 2006. PMID: 17024425
-
Roles of the transcription factors snail and slug during mammary morphogenesis and breast carcinoma progression.J Mammary Gland Biol Neoplasia. 2004 Apr;9(2):183-93. doi: 10.1023/B:JOMG.0000037161.91969.de. J Mammary Gland Biol Neoplasia. 2004. PMID: 15300012 Free PMC article. Review.
-
The epithelial-mesenchymal transition and the estrogen-signaling in ovarian cancer.Curr Drug Targets. 2010 Apr;11(4):474-81. doi: 10.2174/138945010790980385. Curr Drug Targets. 2010. PMID: 20015012 Review.
Cited by
-
Anticancer Activity of Modified Tongyou Decoction on Eca109 Esophageal Cancer Cell Invasion and Metastasis through Regulation of the Epithelial-Mesenchymal Transition Mediated by the HIF-1α-Snail Axis.Evid Based Complement Alternat Med. 2020 Sep 29;2020:3053506. doi: 10.1155/2020/3053506. eCollection 2020. Evid Based Complement Alternat Med. 2020. PMID: 33062005 Free PMC article.
-
miR-200b regulates cell migration via Zeb family during mouse palate development.Histochem Cell Biol. 2012 Apr;137(4):459-70. doi: 10.1007/s00418-012-0915-6. Epub 2012 Jan 20. Histochem Cell Biol. 2012. PMID: 22261924
-
Protein kinase D1 maintains the epithelial phenotype by inducing a DNA-bound, inactive SNAI1 transcriptional repressor complex.PLoS One. 2012;7(1):e30459. doi: 10.1371/journal.pone.0030459. Epub 2012 Jan 20. PLoS One. 2012. PMID: 22276203 Free PMC article.
-
Mesenchymal-to-epithelial transition determinants as characteristics of ovarian carcinoma effusions.Clin Exp Metastasis. 2010 Mar;27(3):161-72. doi: 10.1007/s10585-010-9315-2. Epub 2010 Mar 7. Clin Exp Metastasis. 2010. PMID: 20213325
-
Expression and significance of c-kit and epithelial-mesenchymal transition (EMT) molecules in thymic epithelial tumors (TETs).J Thorac Dis. 2019 Nov;11(11):4602-4612. doi: 10.21037/jtd.2019.10.56. J Thorac Dis. 2019. PMID: 31903249 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous